Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
about
Interventions for reducing inflammation in familial Mediterranean feverInterventions for reducing inflammation in familial Mediterranean feverThe Relationship between NALP3 and Autoinflammatory SyndromesEULAR recommendations for the management of familial Mediterranean feverTreating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesIL-1 blockade in autoinflammatory syndromes.Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey.Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesAn expanding role for interleukin-1 blockade from gout to cancer.Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.Biological treatments: new weapons in the management of monogenic autoinflammatory disordersDivergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.Familial Mediterranean fever: An updated review.Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.Serum Amyloid A Level in Egyptian Children with Familial Mediterranean FeverFamilial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for ManagementImmunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.IL-1β biological treatment of familial Mediterranean fever.Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.FMF50: a score for assessing outcome in familial Mediterranean fever.Monogenic autoinflammatory diseases.Efficacy of interleukin-1 targeting treatments in patients with familial mediterranean Fever.The myths we believed in familial Mediterranean fever: what have we learned in the past years?Biologic therapy in familial Mediterranean fever.Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.Canakinumab Investigated for Treating Familial Mediterranean Fever.Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.[Is there a relationship between gouty arthritis and Mediterranean fever gene mutations?].Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients.Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study.Approach to recurrent fever in childhoodApproche à la fièvre récurrente de l’enfantBiological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety.Familial Mediterranean fever; diagnosis, treatment, and complications.
P2860
Q24187197-D7843751-CAC9-43EE-9CBF-388EF1C7A6DBQ24201537-139B50BF-7456-4C29-9CE7-47D3F8AD815DQ26749025-F7421C4A-030C-46B6-90CD-8F909D7D17BDQ26775286-54942AB8-1E7D-4551-A577-C97FC83E08EFQ26799747-00071E22-56D7-48E1-B11B-2B3364A5AE53Q34262561-1155FFA0-BFF2-4B62-8DA6-199CD532FFF8Q35122583-91406D83-14CF-47DF-8CF2-6FE5F9963DDBQ35133812-00CFD98B-DD8A-4EC6-9C67-9533F218A755Q35219001-A751B1AA-C763-4D2D-B597-B6899F4283B4Q36798016-78F3A29E-72D6-4460-B5C8-03012810B5DFQ36816872-D8672B05-7EBE-4202-9560-1C55F6372A79Q37077564-30B3CF38-349E-4BA1-98BA-46A8AB1BFFECQ37259317-556E6DBA-84CB-4833-BCF1-37538416975BQ37270409-45772BB0-FA1E-4299-BAEE-512BFA886F6BQ37296449-E8D8CDD2-C2C1-4A96-9841-763C3C685A40Q37466515-38AD66E6-D323-425E-ACA7-5B7289328F1AQ37533429-9C004FDD-88A5-4F9F-812F-5372300C96FEQ37716794-78F47916-54F7-4160-95CB-D03F78728289Q37979862-DE5C43F7-B7B0-4B15-9E04-5266133E9357Q38004932-D0CAAE48-70CC-407E-A85D-557CB48BF736Q38074355-477DC376-61C0-4B2E-AC08-2BACB3326D51Q38122566-654D0084-D08A-4E1C-A60D-14E8D3E19EAAQ38151758-CB85E09B-5038-40FD-8574-FFE6CF40C9B0Q38191175-D48A7942-7D27-446C-86E9-9767B793A35BQ38211947-6B4DB641-13DC-46FD-B220-287CD28D58F5Q38241480-68A295F0-1FEE-4F18-AA5F-DF17C7D090DAQ38400573-BECE6080-0B97-4DA3-95D0-AB8053A6FD03Q38759360-F6323D13-D291-47C1-8B31-B292E3B4B4D8Q39301708-F4D3FED2-3CB3-4366-BC9B-1975636B6813Q40079604-EE61055B-06D8-4B85-9AD4-7663164AE0F0Q40089782-8E210E46-A5E9-42D9-AC62-3A2451FDAC57Q40100395-02099CD1-C5F2-46BD-A707-2B26ACDAD330Q40154874-3E76F380-32BE-4B5C-9257-0FBF71411296Q40174107-266C2523-0788-41EB-B2DD-4B56A48159FDQ40176934-3AD38AB6-F5B0-4E8F-AAB4-54112C68EA81Q40199493-255D519F-C9D4-4DBA-A7E9-54AEC96AC608Q42375802-167B9A7E-FC93-4A20-9D42-D02E85A6B235Q42375820-2FDB7039-8CF9-448C-AF91-C68F66AFF20BQ46104569-7C08014B-F699-4C73-9650-B743A315BD0BQ53714230-2AD68DB8-3C28-4943-B7DA-EF1180D1739F
P2860
Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Anti-interleukin 1 treatment f ...... fever resistant to colchicine.
@en
type
label
Anti-interleukin 1 treatment f ...... fever resistant to colchicine.
@en
prefLabel
Anti-interleukin 1 treatment f ...... fever resistant to colchicine.
@en
P2093
P356
P1476
Anti-interleukin 1 treatment f ...... fever resistant to colchicine.
@en
P2093
Meral Calguneri
Nuray Aktay Ayaz
Yelda Bilginer
P304
P356
10.3899/JRHEUM.100718
P407
P577
2010-12-15T00:00:00Z